ISOFLURANE AS A ROUTINE ANAESTHETIC IN GENERAL SURGICAL PRACTICE J. F. NUNN
Isoflurane became available in the United Kingdom at the end of 1983. Since 1971 there has been a greater volume of publications on the pharmacology of this agent than has preceded the advent of any other anaesthetic agent. In contrast, however, there have been relatively few publications describing its clinical use and, in particular, there has been no account of its use in the United Kingdom, where the circumstances of surgery and clinical anaesthesia differ in many respects from North America, where it has been in general use since 1982. Thus, it appeared appropriate to give a brief account of its routine use in a British District General Hospital during the period from late 1983 to early 1984.
PATIENTS AND SURGERY
During the period of this study, isoflurane was used for every patient whom the author anaesthetized and its use was continued in all except two patients until shortly before the end of surgery. Since isoflurane had a product licence, its use for general anaesthesia was regarded as routine clinical practice, and no approach was made to the ethics committee. All anaesthetics were administered either by the author or by a trainee under his direct supervision.
The series comprised 135 consecutive patients ranging in age from 2 months to 95 yr (table I). All surgery was elective and the patients were predominantly in ASA groups I, II and III (table II). The incidence of concomitant disease is shown in table III, and medication prescribed before operation, in table IV. The range of surgical operations was governed by the repertoire of the surgeons with whom the author works and did not include gynaecological, obstetric, orthopaedic, otorhino- laryngological, ophthalmic, cardiac, thoracic or neurosurgical procedures (table V) .
SUMMARY

ANAESTHESIA
Premedication
Most adults received papavereturn 10-20 mg and hyoscine 0.2-0.4 mg. In patients older than 60 yr, the hyoscine was replaced by atropine 0.6 mg. Phenergan 25 mg, atropine 0.6 mg and pethidine 50mg were used in three patients with asthma or chronic bronchitis. A few patients for repeat cysto- 17  8  6  6  6  4  3  3  2  2  2  1  1  1  1  1  1  1 scopy were content with either no premedication or oral temazepam 10-20 mg. The four children younger than 1 yr received, respectively, no premedication, atropine 0.1 mg (two children) and 0.2 mg (one child). Children between the ages of 2 and 7 yr received trimeprazine 3 mg kg" 1 , by mouth, followed by papaveretum 3-5 mg and hyoscine 0.06-0.1 mg i.m. They arrived in the anaesthetic room asleep but rousable. 
Induction
All patients older than 7 yr received thiopentone 100-400 mg. The 11 patients younger than 8 yr received an inhalation induction using isoflurane vaporized in oxygen.
Maintenance
Neuromuscular blocking drugs were administered to 59 patients (table VI), no patient receiving more than one such drug. Suxamethonium was used to facilitate the passage of a tracheal tube in four patients, who then breathed spontaneously. In the remaining 55 patients, all adults, the lungs were ventilated artificially, anaesthesia being maintained with isoflurane vaporized in 65% nitrous oxide in oxygen using a non-rebreathing system and a Manley ventilator set to deliver a minute volume of 6-9 litre min" 1 . The mean duration of the administratin of isoflurane in patients ventilated artificially was 87 (SD 24) min.
The 71 patients older than 5 yr who breathed spontaneously received isoflurane vaporized in 65% nitrous oxide in oxygen using a Magill system with a Nine patients younger than 6 yr received the same mixture from a Jackson Rees T-piece system. The inspired concentration of isoflurane was adjusted to prevent spontaneous movement in response to surgical stimulation. The duration of administration of isoflurane ranged from. 10 to 75 min in all except one patient, in whom it was 165 min. Excluding this patient, the mean duration was 32 (SD 26) min.
Analgesia
For relief of early postoperative pain, eight patients received regional blockade with bupivacaine before incision. These were mainly intercostal nerve blocks in patients scheduled for cholecystectomy (0.5% bupivacaine 20 ml) and penile blocks for those requiring circumcision. In a further 11 patients, the area of the incision was infiltrated with 0.25% bupivacaine at the end of the operation. The only opiate used during operation was morphine and this was administered towards the end of the operation in 13 patients in a mean dose of 5 mg (SD 2 mg).
Adrenaline
The surgeons infiltrated the line of the incision with 1:200 000 adrenaline for most patients undergoing thyroidectomy, parathyroidectomy or nephrectomy. Twenty-two patients received a mean dose of adrenaline 3.35 ug kg" 1 (SD 1.12) (table VII).
Monitoring
The electrocardiogram was observed on a monitor screen (CM 5 lead) during surgery in 110 patients. Arterial pressure was measured either by the Riva Rocci method or with an oscillotonometer. Heart rate was measured electrically from a pulse signal derived from optical transmission through the lobe of the ear.
The vaporizer
The same Cyprane vaporizer calibrated for isoflurane was used for both induction and maintenance throughout the series. It was also calibrated in our own laboratory and found to deliver concentrations within 10% of dial readings, at the carrier gas flow rates used in the study. The error was high at settings of 1 and 2% and low at settings from 3 to 5%. The rate at which the delivered concentration decreased when the level of isoflurane decreased below the bottom of the sight glass was measured during a continuous flow of nitrous oxide 4 litre min" 1 + oxygen 2 litre min" 1 at a setting of 3% using a Datex Normac infra-red analyser. Gradients of isoflurane concentration in the gas system resulting from loss of isoflurane into the rubber parts of the system were measured using the same analyser, which was also used for measuring the rate of decrease of the end-tidal isoflurane concentration when the inspired concentration was reduced from 1% to zero.
RESULTS
There was no mortality in the series and no significant morbidity attributable to anaesthesia. There was no indication that any patient had recall of events during anaesthesia or surgery.
Inspired concentrations ofisoflurane
In the patients receiving neuromuscular blocking drugs and artificial ventilation, the initial setting for the inspired isoflurane concentration was 1% and remained at this value until shortly before the end of the operation in 19 patients. Concentrations ofisoflurane were increased for all or part of the anaesthetic in 19 patients (table VIII). In nine patients this was because the arterial pressure appeared to be increasing in response to surgery (mean systolic pressure 150 mm Hg). Concentrations ofisoflurane were decreased for all or part of the anaesthetic in 19 patients, in five of whom the arterial pressure appeared to be decreasing in response to anaesthesia (mean systolic pressure 72 mm Hg). In the remaining 14 patients, a lower concentration was used because of a clinical assessment of the requirement of isoflurane for a particular patient without any objective indication of the necessity for the use of the lower concentration. Patients who were able to breathe spontaneously and had received thiopentone were able to tolerate an initial inspired concentration of 2% isoflurane without coughing. This could then be increased to 4 or 5% within the course of about 1 min. Children who had not received thiopentone would tolerate 1% initial inspired concentration whether asleep or awake and this could be increased progressively to 4% within about 90 s, loss of eyelash reflex usually occurring within the same time. It is not possible to relate inspired concentrations to the time to loss of consciousness with any precision because, initially, the mask was held clear of the face in the sleeping children and, therefore, the actual inspired concentration at this time was in doubt. However, induction was clearly very rapid.
During the maintenance of anaesthesia with spontaneous breathing, the inspired concentration was adjusted to prevent response to surgical stimulus, and experience of the required concentration increased as the series proceeded. The mode of the maximal concentration was 2%, but ranged from 1 to 4% (table IX) . Concentrations of 3 or 4% were used on four occasions because the systolic arterial pressure had increased to 160 mm Hg or above. In the other patients it was used for short periods of time in anticipation of severe surgical stimulation (e.g. circumcision), and in children in whom higher concentrations were needed generally to secure surgical anaesthesia. The response to changing the inspired concentrations was very rapid, such that the depth of anaesthesia could be increased rapidly, and the arterial pressure controlled readily.
Recovery and time-course of wash-out of alveolar isoflurane
Very little time was available for tracheal intubation under isoflurane in patient number 100 (aged 2 months) because of the rapidity of lightening of anaesthesia when the mask was removed from the face before laryngoscopy. Three wash-out curves were recorded in two adults during artificial ventilation after a minimum of 1 h of inhalation of 1% isoflurane ( fig. 1 ). The mean half-time of the rate of reduction of alveolar isoflurane was 27 s. Most patients were rather heavily premedicated and no attempt was made to achieve rapid awakening from anaesthesia. However, 14 patients were responding to commands within 5 min of the end of inhalation anaesthesia and a further 27 within 10 min.
Heart rate
The mean heart rate before induction was 78.4 (SD 17.5) beat min" 1 . During anaesthesia, the timeweighted mean rate was 83.4 (SD 24.6) beat min" 1 , the difference being just significant (P = 0.05). Before induction, heart rates were much higher in children up to the age of 10 yr (mean 111.7, SD 24.2 beat min ). During anaesthesia, the time-weighted mean rate was 131.7(SD36.3) beat min" 1 , the difference being significant (P < 0.05).
There was a very variable response to the anaesthetic. In 46 patients, the rate did not change by more than ± 1 0 beat min" 1 from the preoperative value ( fig. 2) . In 38 patients, the minimal rate during anaesthesia decreased to less than the preoperative value by more than 10 beat min" 1 and in 51 the maximal value increased above the preoperative value by more than 10 beat min" 1 (excluding measurements after atropine in the course of reversal of a neuromuscular blocking drug). In 92 patients the fastest heart rate during anaesthesia was in the range 60-100 beat min" 1 (excluding the period of administration of atropine before reversal of neuromuscular blockade). However, the range extended upwards to 150 beat min" 1 in adults and 200 beat min" 1 in children ( fig. 3 ). The patients with the highest rates and the greatest changes are shown in table X and figure 4.
Arterial pressure
In most patients, arterial pressure responded rapidly to changes in the inspired concentration of isoflurane and, with neuromuscular blockade and artificial ventilation, the pressure could be controlled readily by alterations in the inspired isoflurane concentration. In patients ventilated artificially the systolic pressure decreased to 60 mm Hg in two patients, 70 mm Hg in eight, and 80 mm Hg in 10 patients. Significant increases in arterial pressure occurred in two patients ( fig. 5) . In patient No. 117, the increases in arterial pressure were not fully con- FIG. 2. Histogram of maximal changes from pre-induction heart rates (excluding observations made after administration of atropine before the use of neosugmine). There is a negative correlation between the change for each group and the mean heart rate before induction (r = -0.83). trolled with 2% isoflurane and required phentolamine 0.5 mg once during and once after the end of the operation. The arterial pressure remained greater than 180 mm Hg systolic for 2 h in the period after operation. In patient No. 119, the arterial pressure increased from a pre-induction value of 140/80 mm Hg to 170/100 mm Hg, but this was easily controlled by increasing the inspired concentration of isoflurane from 1 to 2%. In those patients breathing spontaneously, it was possible to maintain an adequate depth of anaesthesia without the systolic arterial pressure decreasing to less than the values shown in table XI.
Cardiac rhythm
One hundred and one of the 110 monitored patients remained in sinus rhythm throughout surgery. Three patients had atrial fibrillation before surgery and this continued unchanged during the anaesthetic. Another patient had pre-existing atrial extrasystoles and these also continued during surgery. Changes in rhythm occurred in five patients (table XII) in whom no abnormalities in rhythm were observed before surgery. Quite large doses of adrenaline were used in three of these patients, one of whom developed ventricular extrasystoles (1 min" 1 ) while two developed periods of nodal rhythm. Patient No. 9 developed fibrillation/flutter at the end of the anaesthetic but the same abnormality of rhythm occurred in two subsequent anaesthetics for repeat cystoscopy, halothane being the main agent for one and enflurane for the other. On each occasion the patient reverted to normal sinus rhythm early in the period after operation. Substantial doses of adrenaline were administered to 19 patients in addition to those listed in table XII, Table VI shows the doses which were required to maintain adequate surgical relaxation. The doses of atracurium and vecuronium are plotted against the duration of the period of the operation requiring relaxation ( fig. 6 ). All patients receiving pancuronium, fazadinium, alcuronium and vecuronium required neostigmine 2.5-5 mg to give a sustained tetanus at the end of surgery. However, in eight of the 14 patients receiving atracurium, neuromuscular conduction appeared adequate and neostigmine was not used. They are shown as open circles in figure 6 , and the requirement for neostigmine did not appear to depend upon the dose in relation to duration of operation.
Difficulty was encountered in reversing neuromuscular blockade in one patient weighing 78 kg (No. 11) who received alcuronium 20 + 10 mg in the course of a pyelolithotomy lasting 90 min. It was not possible to obtain a sustained tetanus following the administration of neostigmine 5 mg at the end of operation and anaesthesia was maintained with nitrous oxide for a further 1 h, after which there was a good response to an additional neostigmine 2.5 mg. Inspired isoflurane concentration was 1% until 20 min before the end of operation, when it was reduced to 0.5%. 
Untoward events
Generally, the course of anaesthesia was uneventful. One patient coughed unexpectedly during a transurethral resection of prostate after breathing 3% isoflurane for 5 min and 1.5% isoflurane for a further 10 min. A child of 5 months who had not received premedication had troublesome secretions during anaesthesia, but these responded rapidly to the administration of atropine 0.2 mg. The most difficult problem arose in two children aged respectively 2 and 4 months, who had intermittent periods of apnoea during anaesthesia. In each case the inspired concentration of isoflurane was in the range 1.5-3%. Respiration was not obstructed and anaesthesia appeared to be neither too deep nor too light. Neither child responded to surgical stimulation, and the lungs of both were ventilated by manual compression of the reservoir bag. At the end of surgery, when the inspired isoflurane concentration was reduced to zero, normal breathing rapidly returned and each child awoke while still on the operating table.
In the early period after operation, five patients vomited. Three shivered for a few minutes, one was restless and another was confused and disorientated for the first 1 h. The most difficult problems in the period after operation were two patients who became delirious. Each had to be restrained for several minutes, and they did not respond to morphine i.v.
Consumption of isoflurane
On average 22 ml of liquid isoflurane was administered per patient. The patients comprised 80 who breathed spontaneously with a median inspired concentration of 2% and a mean duration of 32 min, and a further 55 who were ventilated artificially with a median inspired concentration of 1% and a mean duration of 87 min. Fresh gas flow ranged from 6 to 9 litre min"'.
Effect of exhaustion of isoflurane in the vaporizer
At a flow rate of carrier gas 6 litre min" 1 the vaporizer, set to a nominal concentration of 3%, actually delivered 2.8% isoflurane. From the time the level of isoflurane formed a diameter across the lower port of the sight glass until it formed a tangent to the bottom of the port took about 20 min, during which the concentration decreased from 2.8 to 2.7%. Thereafter, the delivered concentration decreased precipitously to less than 1% in 6 min ( fig. 7A ).
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Concentration gradients urithin the gas circuit
With a standard Magill system, the concentration of isoflurane delivered to the patient was 2.7% when the concentration leaving the vaporizer was 2.8% ( fig. 7B ). The mixture had been passing through the circuit for 30 min before the measurements were made. The flexible parts of the circuit were made of black conductive rubber.
DISCUSSION
The authur made an abrupt transition to the exclusive use of isoflurane for this series of 135 patients, without any previous practical experience of the agent. While this presented no major difficulty, there was a definite learning curve and the quality of anaesthesia improved as experience was increased.
No clear contraindications to the use of isoflurane have been reported and none emerged in this study, in relation to either the type of surgery or pre-existing disease.
Induction
For all the adult patients, anaesthesia was induced with thiopentone. Immediately thereafter all patients tolerated an inspired concentration of 2% isoflurane without coughing. However, without thiopentone, 2% isoflurane was found to be irritant, imparting a distinctive burning sensation in the back of the nose. Therefore, when thiopentone was not used, it was necessary to commence with 1% isoflurane although this could be increased to 2% after a few breaths. This contrasts with halothane, which can be breathed at 2% concentration by the conscious patient. Thus, halothane is initially tolerable at 2.6 MAC multiples and isoflurane at only 0.8 MAC multiples. Therefore, in spite of the lower blood solubility of the latter, induction was proved to be no quicker than with halothane (Pandit, Leach and Steude, 1983 ).
In the case of small children, induction was by isoflurane vaporized in oxygen to avoid the cerebral arousal caused by nitrous oxide. Nitrous oxide was introduced to the mixture after the child had lost consciousness. With the inspired concentration of isoflurane increasing according to the schedule outlined above, loss of consciousness usually occurred within 1 min and always within 90 s, although the mask was initially held clear of the face for approximately 20-30 s.
Maintenance of anaesthesia
During the maintenance of anaesthesia without neuromuscular blockade, the mean of the maximal inspired concentration required was 2.3% which, after about 1 h of anaesthesia, would result in an alveolar concentration of about 1.6% (Cromwell et al., 1971) or 1.2 MAC multiples. Allowing an additional 0.6 MAC multiples for the use of 65% nitrous oxide, the total would be of the order of 2.2 MAC multiples, which is a reasonable value to secure free-dom from response to maximal surgical stimulus in the great majority of patients. In fact, only one patient responded overtly to surgical stimulation by coughing, on one occasion in this study. In patients receiving neuromuscular blocking drugs the inspired concentration was much more constantwith a mean value of 1.1%.
Homi and his colleagues (1972) reported inspired concentrations of isoflurane in the range 1.2-2.5% during maintenance of anaesthesia with a 50% nitrous oxide in oxygen mixture as carrier gas.
Values in the present study cannot easily be compared with those reported in the North American Multicentre trial (Cahalan, 1982) , in which no distinction was made in reporting concentrations for patients with and without neuromuscular blockade. Furthermore, reported concentrations were those delivered into the system and were not necessarily the same as the inspired concentration, since rebreathing circle systems with soda-lime were generally used, and the fresh gas flow rate was not specified. Nevertheless, during the maintenance of anaesthesia the mean value for the highest concentration of isoflurane delivered to the gas circuit was 1.7% and for the average concentration was 1.2% (Cahalan, 1982) . The range of delivered concentrations was 0.4-3.2%, which seems to be in general accord with the present study.
Recovery
Although the mildly irritant smell of isoflurane delays the rapidity of induction, recovery is determined predominantly by the low solubility of the agent in body fluids and is, therefore, very rapid. The wash-out curves ( fig. 1 ) relate to adults ventilated artificially at 6 litre min" 1 after 1 h of equilibration with 1% isoflurane and cannot, therefore, be compared directly with the data of Cromwell and colleagues (1971) , who studied the elimination of sub-anaesthetic concentrations of isoflurane in volunteers breathing spontaneously. Nevertheless, in that study, alveolar partial pressure reached 37% of the initial arterial tension at the end of the first minute of wash-out after 64 min inhalation of 0.25% isoflurane, a time-course which is compatible with our own data.
The quality of recovery was remarkably good and the incidence of nausea, vomiting, shivering and distress was minimal, and decreased with experience. The only major problem was delirium, which occurred in two patients, requiring restraint by more than one nurse and not responding to morphine i.v.
Homi and his colleagues (1972) reported postoperative excitement and delirium in 6% of their patients, while Pauca and Dripps (1973) observed mild excitement in 12% and moderate excitement in 3% of their patients. Emergence delirium occurred in 3.2% of patients reported in the American New Drug Application for Isoflurane (p.642), although the incidence after halothane was not significantly different. Emergence delirium was also noted by White (personal communication) during a study of totally closed circuit isoflurane anaesthesia without the use of nitrous oxide or opiates. I concur with the view of Pauca and Dripps (1973) that the condition is caused by sudden perception of postoperative pain as a result of the rapid wash-out of isoflurane. The condition is seen at its worst after painful procedures (e.g. upper abdominal or renal surgery) in which regional anaesthesia or opiates have not been used. In the present series, the two cases of delirium occurred early in the series. Patient No. 14 had undergone a vagotomy and pyloroplasty, and patient No. 15 an excision of parotid tumour, neither having received regional anaesthesia or opiate before recovery. Thereafter, this complication appeared to be avoided in potential cases by the use of either regional anaesthesia or an opiate before recovery commenced. This problem might well be encountered during the early exploratory use of isoflurane, when the use of regional anaesthesia and opiates are minimized to facilitate observations of the effects of isoflurane itself.
Heart rate
Early clinical experience drew attention to the increase in heart rate (Homi et al., 1972; Pauca and Dripps, 1973) . The Multicentre Trial (Forrest, 1982) reported a mean heart rate of 87.71 beat min" 1 before induction, which may be compared with 78.4 beat min" 1 in the present series. They reported a mean "typical" heart rate of 89.99 beat min" 1 during maintenance of anaesthesia, which may be compared with the time weighted mean of 83.3 beatmin" 1 reported here. The standard error of the mean "typical" heart rate in the Multicentre Trial was 0.29, corresponding to a standard deviation of 22.26 in a study of 6798 patients. Assuming normal distribution, this would indicate a 95% range extending up to 149.63 beat min" 1 . As in the present series, the Multicentre Trial found the "typical" heart rate during anaesthesia to be markedly agedependent. For patients younger than 1 yr, the mean was 149.9 (SD 19.5) beat min ', indicating a 95% range extending to about 190 beat min" 1 , which may be compared with a mean of 159 (SD 30) beat min" 1 for the small number of patients younger than 1 yr in the present study.
The Multicentre Trial reported a mean value for the maximal heart rate during anaesthesia of 101.81 (SD 23.9) beat min" 1 , which may be compared with the values in figure 3 . The Multicentre Trial does not report age-dependence of the fastest heart rate during maintenance, but this is clearly shown in figure 3 . Figure 4 shows no clear relationship between inspired concentration of isoflurane and the heart rate, although the tachycardia does seem to be related to the duration of anaesthesia. In reporting the present series, it seemed useful to identify those patients in whom there was either a maximal heart rate of more than 120 beat min" 1 or an increase of more than 40 beat min" 1 compared with the value before induction (table X). Four of seven .patients who received fazadinium fell into one of these categories. Since fazadinium has now been withdrawn from clinical use, this observation is of theoretical interest only. Eight of the remaining 10 patients in table X were children, and in five of these the heart rate was within the upper limit of normal (Davenport, 1980) . There remain five patients exhibiting appreciable tachycardia (fig. 4) . None had any appreciable blood loss or pyrexia and none gave any cause for anxiety apart from the tachycardia which was not treated.
In most instances, tachycardia occurred in young patients in whom there was no cause for concern about increased myocardial work resulting from the increased rate-pressure product. The ST segment remained unchanged in all monitored patients using the CM 5 lead configuration. This also applied to the 17 patients who had pre-existing myocardial ischaemia or angina. Figure 2 shows an inverse relationship between mean heart rate before induction and the change in heart rate of each group following induction. This relationship is significant (P < 0.01).
The slowest heart rates recorded were 40 beat min" 1 in two patients and 45 beat min" 1 in another three patients.
Arterial pressure
Isoflurane is a potent hypotensive agent, an effect achieved predominantly by a reduction in systemic vascular resistance rather than by a decrease in cardiac output (Eger, 1981) . Thus, its effect resembles, in some respects, that of sodiurrPnitroprusside. In the present study, the ability to maintain an adequate depth of anaesthesia was never compromised by hypotension to less than the values shown in table XI, which were considered acceptable in a supine patient with no clinical indication of defective peripheral circulation. It was generally very easy to control an increasing arterial pressure with isoflurane, but an exception was patient 117 (fig. 5 ). This patient was in normal health before and after operation and there was nothing to suggest the possibility of a phaeochromocytoma.
Cardiac rhythm
An outstanding feature of isoflurane in the present series was the stability of the cardiac rhythm. Patient No. 1 exhibited one monofocal ventricular extrasystole per minute following administration of adrenaline (table XII) . Two other patients developed episodes of nodal rhythm after adrenaline, and this change was also observed by Johnston, Eger and Wilson (1976) . Otherwise, the substantial doses of adrenaline recorded in table VII were without effect. Johnston, Eger and Wilson (1976) found the ED 50 of adrenaline for initiation of ventricular extrasystoles during isoflurane anaesthesia to be 6.72 (SD 0.66) [xg/kg body weight. One of their patients developed arrhythmia after a dose of 5.5 ug kg" 1 , which was the largest dose used in the present series. The minimal response to the dose range of adrenaline in the present study supports Johnston's evidence for its safety. The fact that patient No. 9 developed fibrillation/flutter at the end of three consecutive anaesthetics, all with different agents, suggests that he was responding to the general stress of anaesthesia and surgery rather than to any particular anaesthetic agent.
Respiration
British anaesthetic practice has long differed from that of the United States in its tolerance of unassisted spontaneous respiration for a wide range of surgical procedures not requiring the use of a neuromuscular blocking drug. With halothane as the main anaesthetic agent, minute volumes of respiration may decrease to as low as 2.3 litre min" 1 with arterial PCO2 increasing to 9 kPa, but without demonstrable harm to the patient (Nunn and Hill, 1960; Nunn, 1964) .
In volunteers, anaesthetized with isoflurane without surgical stimulation, there is evidence that iso-flurane is a more powerful respiratory depressant than halothane (Fourcade et al., 1971) . However, the addition of nitrous oxide and surgical stimulation greatly reduces the hypercapnia resulting from the use of isoflurane (Eger, 1981) . It would be difficult to predict the degree of respiratory depression under the conditions of the present series. However, there was no clinical evidence of any greater respiratory depression than is normally seen with halothane under similar conditions. In patient No. 66, spontaneous respiration was maintained during a mastopexy lasting for 165 min. In view of the duration of operation, arterial PCO2 was measured at the end of operation and was 7.9 kPa, which is within the range encountered by the author under similar circumstances using halothane (Nunn, 1964) .
Relaxation
No attempt was made to achieve surgical relaxation with isoflurane in the present series. In the 55 patients who were ventilated artificially, tracheal intubation was achieved, not with suxamethonium, but with one of the first five neuromuscular blocking drugs listed in table VI. The initial dose of the neuromuscular blocker was calculated to provide sufficient relaxation for intubation at a time when the alveolar concentration of isoflurane was low. Therefore, it was not possible to make any assessment of potentiation of neuromuscular block by isoflurane. However, repeat dosage of the long acting drugs, pancuronium, fazadinium and alcuronium, was only required in five patients, in spite of the duration of operation which greatly exceeded the normal duration of action of the drugs concerned. Peritoneal closure never required a supplementary dose of the neuromuscular blocker, and it seems likely that this was the result of potentiation by isoflurane, usually at an inspired concentration of 1%. Reversal with neostigmine was always used and presented no difficulty except in patient No. 11 referred to above. Dosage of the short acting drugs atracurium and vecuronium gave no obvious indication of any potentiation by isoflurane ( fig. 6 ). Dosage of atracurium appears similar to the range of 0.005-0.01 mg kg" 1 min" 1 reported by Flynn and colleagues (1983) in patients not receiving a volatile anaesthetic.
Anaesthetic apparatus
Isoflurane has a lower solubility in conductive rubber tubing than have other volatile agents (Eger, 1981) , the solubility coefficient being only one-tenth that of methoxyflurane. Figure 7B shows the negligible loss of concentration during transit through a conventional Magill system.
The accuracy of the vaporizer available to us was within 10% of nominal delivered concentration and was adequate for clinical use. It was, however, startling to observe the rapidity of decrease in delivered concentration once the fluid level had fallen below the lower rim of the lower port of the sight glass ( fig.  7A ). Taken in conjunction with the very rapid washout of alveolar isoflurane ( fig. 1) , it is clear that the utmost vigilance must be exercised to be certain that the vaporizer never becomes empty during use.
CONCLUSIONS
The present study indicates that isoflurane is a very satisfactory anaesthetic agent which is applicable to a wide range of surgery. It would appear to have important advantages, particularly since so many favourable qualities appear to be combined in the one agent.
Minor disadvantages include the mildly irritant nature of the vapour, which demands some skill and experience to achieve the best results during an inhalation induction and also slightly limits the speed of induction. The occasional case of tachycardia may cause some concern and wider experience will be needed to assess its importance in the clinical environment. It appears that emergence delirium can be avoided by appropriate care to prevent the sudden appreciation of pain on awakening from anaesthesia.
It is unlikely that anyone will overlook the fact that isoflurane is considerably more expensive than enflurane and very much more expensive than halothane. The mean utilization of liquid isoflurane 22 ml per patient in this study accords with the high fresh gas flow rates and the delivered concentrations. Essentially non-rebreathing systems were used so that the inspired concentration of isoflurane should be known. However, substantial economies could be achieved by reduction in fresh gas flow rates or by the use of closed circuit anaesthesia (O'Callaghanetal., 1983) .
There is, of course, a learning curve in the use of any new technique or drug. Isoflurane is no exception and results in the present series improved with experience. Thus 10 of the postoperative complications mentioned above were encountered in the first 50 patients and only two in the following 85 patients.
Although this and other studies have shown that isoflurane is generally a very satisfactory agent, there is now a need for comparative studies with other volatile agents in the clinical environment. This study, those of Dobkin and colleagues (1971) , Homi and co-workers (1972), Pauca and Dripps (1973) and the Multicentre Trial have not attempted to make a controlled comparison of isoflurane with other volatile agents in the context of routine surgery. This should now be undertaken.
